Clinical Trial: Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants

U.S., Nov. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07223671) titled 'Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants' on Oct. 30.

Brief Summary: The purpose of the study if to evaluate the effect of Repotrectinib on the drug levels of transporter and CYP P450 probe substrates in healthy adult participants.

Study Start Date: Nov. 12

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: Repotrectinib

Specified dose on specified days

DRUG: Metformin

Specified dose on specified days

DRUG: Digoxin

Specified dose on specified days

DRUG: Rosuvastatin

Specified dose on specified days...